LAKE ZURICH, Ill., March 27, 2025 — Fresenius announced that the Biologics License...
Author - David Miller
Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib)...
ALAMEDA, Calif.–(BUSINESS WIRE)–Mar. 26, 2025– Exelixis, Inc. (Nasdaq: EXEL)...
Biorasi: Director, Business Development
depending on your experience: Biorasi: We are Growing! Let us support your career journey the...
Enzyme engineering opens door to novel therapies for...
Scientists have long struggled to target proteins that lack defined structure and are involved in...
FDA Approves Vykat XR (diazoxide choline) to Treat Hyperphagia...
REDWOOD CITY, Calif., March 26, 2025 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (NASDAQ:...
FDA Approves Blujepa (gepotidacin) for the Treatment of...
London, UK — 25 March 2025 — GSK plc (LSE/NYSE: GSK) today announced that the US Food...
UK Biocentre: Director, Business Development
Competitive: UK Biocentre: Lead the commercial future of the UK Biocentre - drive strategic...
New tool to boost cancer immunotherapy effects
Among other functions, the NK cells (Natural Killers, a type of lymphocyte forming part of the...
Theratechnologies Receives FDA Approval for Egrifta WR...
MONTREAL, March 25, 2025 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies”...
Scientists identify potential new genetic target for sickle cell...
Scientists from Johns Hopkins Medicine and eight other institutions in the United States, Africa...